secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001213900-22-013457
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed CFO Bruce Colwill retiring; Brenda Edwards named interim CFO
------------------------------------------------------------------

- Bruce Colwill steps down as CFO effective March 31, 2022; will remain advisor through June 30, 2022.
- Brenda Edwards appointed interim CFO effective April 1, 2022; over 35 years of experience including 20+ years as CFO.
- Company has initiated a search for a permanent CFO replacement.
- Ms. Edwards engaged through a placement agency at CAD$210/hour.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/0001213900-22-013457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022013457/ea157098-8k_inmedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-013457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer